Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)

Thomas Jefferson University

Status: Withdrawn

Conditions: Heart Failure

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02026635

13P.296

Details and patient eligibility

About

A research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least 18 years of age
• Admission for worsening of HF
• Discharged to home
• Have appropriate cardiac device with OptiVol® implanted for at least 34 days prior to enrollment
• Enrolled in Carelink® system and able to transmit data
• Able to participate for at least 3 months

Exclusion criteria

• Post heart transplant or actively listed
• End-stage (Stage D) HF, including treatment with chronic ionotropic drugs or left ventricular assist device support
• Stage IV or V chronic renal dysfunction (GFR <25 mol/min per 1.73 M2)
• Severe Chronic Obstructive Pulmonary Disease (COPD) requiring home oxygen
• Severe pulmonary hypertension not due to left-sided HF

Trial design

0 participants in 1 patient group

Optivol® Device in CareLink

Description:

A single cohort group of heart failure patients with already implanted Optivol® capable devices who are discharged home from the hospital